CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GenMark Diagnostics, Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GenMark Diagnostics, Inc
5964 La Place Ct
Phone: (760) 448-4300p:760 448-4300 Carlsbad, CA  92008-8829  United States Ticker: 0IUT0IUT

This company was Merged or Acquired on 4/22/2021.
This company ceased filing statements with the SEC on 5/3/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202012/31/2020YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Kevin C.O'Boyle 64 2/1/2020 3/1/2010
President, Chief Executive Officer, Director ScottMendel 53 5/4/2020 5/13/2014
Chief Financial Officer JohnnyEk 43 2/18/2019 2/18/2019
10 additional Officers and Directors records available in full report.

Business Names
Business Name
0IUT
Clinical Micro Sensors, Inc.
GenMark Diagnostics Europe GmbH
6 additional Business Names available in full report.

General Information
Number of Employees: 618 (As of 12/31/2020)
Outstanding Shares: 73,595,021 (As of 3/11/2021)
Shareholders: 742
Stock Exchange: NASD
Federal Tax Id: 272053069
Fax Number: (760) 448-4301


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 1, 2024